Usefulness of Combining Serum Uric Acid and C-Reactive Protein for Risk Stratification of Patients With Coronary Artery Disease (Bezafibrate Infarction Prevention [BIP] Study)

American Journal of Cardiology

Volumn 104, Issue 2, 2009, Pages 194-198

  Brodov, Yafim ^a   Behar, Shlomo ^a   Goldenberg, Ilan ^a   Boyko, Valentina ^a   Chouraqui, Pierre ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; URIC ACID;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; FATALITY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STRATIFICATION; SUDDEN DEATH; URIC ACID BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; ANTILIPEMIC AGENTS; BEZAFIBRATE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; URIC ACID;

EID: 67649361513     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.03.017     Document Type: Article

References (30)

1. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
2. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
3. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., Curhan G.C., Rifai N., Cannuscio C.C., Stampfer M.J., and Rimm E.B. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 (2004) 2599-2610
4. Haim M., Benderly M., Tanne D., Matas Z., Boyko V., Fisman E.Z., Tenenbaum A., Zimmlichman R., Battler A., Goldbourt U., and Behar S. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease. Am Heart J 154 (2007) 1095-1101
5. Baker J.F., Krishnan E., Chen L., and Schumacher H.R. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med 118 (2005) 816-826
6. Meisinger C., Koenig W., Baumert J., and Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population. The MONICA/KORA Cohort Study. Arterioscler Thromb Vasc Biol 28 (2008) 1186-1192
7. Ruggiero C., Cherubini A., Miller III E., Maggio M., Najjar S.S., Lauretani F., Bandinelli S., Senin U., and Ferrucci L. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 100 (2007) 115-121
8. Caravaca F., Martín M.V., Barroso S., Cancho B., Arrobas M., Luna E., and Sánchez-Casado E. Serum uric acid and C-reactive protein levels in patients with chronic kidney disease. Nefrologia 25 (2005) 645-654
9. Coutinho Tde A., Turner S.T., Peyser P.A., Bielak L.F., Sheedy II P.F., and Kullo I.J. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20 (2007) 83-89
10. Haim M., Benderly M., Tanne D., Matas Z., Boyko V., Fisman E.Z., Tenenbaum A., Zimmlichman R., Battler A., Goldbourt U., and Behar S. C-reactive protein distribution and correlates among men and women with chronic coronary heart disease. Cardiology 107 (2007) 345-353
11. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 102 (2000) 2-4
12. Rehak N.N., Janes G., and Young D.S. Calorimetric enzymic measurement of uric acid in serum. Clin Chem 23 (1977) 195-199
13. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Hogg R.J., Perrone R.D., Lau J., and Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
14. Madsen T.E., Muhlestein J.B., Carlquist J.F., Horne B.D., Bair T.L., Jackson J.D., Lappe J.M., Pearson R.R., and Anderson J.L. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease. Am J Nephrol 25 (2005) 45-49
15. Bickel C., Rupprecht H.J., Blankenberg S., Rippin G., Hafner G., Daunhauer A., Hofmann K.P., and Meyer J. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89 (2002) 12-17
16. Anker S.D., Doehner W., Rauchhaus M., Sharma R., Francis D., Knosalla C., Davos C.H., Cicoira M., Shamim W., Kemp M., Segal R., Osterziel K.J., Leyva F., Hetzer R., Ponikowski P., and Coats A.J. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107 (2003) 1991-1997
17. Høieggen A., Alderman M.H., Kjeldsen S.E., Julius S., Devereux R.B., De Faire U., Fyhrquist F., Ibsen H., Kristianson K., Lederballe-Pedersen O., Lindholm L.H., Nieminen M.S., Omvik P., Oparil S., Wedel H., Chen C., and Dahlöf B. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 65 (2004) 1041-1049
18. Gerber Y., Tanne D., Medalie J.H., and Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 13 (2006) 193-198
19. Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., and Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36 (2000) 1072-1078
20. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., and Rosamond W.D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) study. Ann Epidemiol 10 (2000) 136-143
21. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131 (1999) 7-13
22. De Leeuw P.W., Thijs L., Birkenhäger W.H., Voyaki S.M., Efstratopoulos A.D., Fagard R.H., Leonetti G., Nachev C., Petrie J.C., Rodicio J.L., Rosenfeld J.J., Sarti C., and Staessen J.A. Prognostic significance of renal function in elderly patients with isolated systolic hypertension. J Am Soc Nephrol 13 (2002) 2213-2222
23. Waring W.S., Adwani S.H., Breukels O., Webb D.J., and Maxwell S.R. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 90 (2004) 155-159
24. Athyros V.G., Mikhailidis D.P., Liberopoulos E.N., Kakafika A.I., Karagiannis A., Papageorgiou A.A., Tziomalos K., Ganotakis E.S., and Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study. Nephrol Dial Transplant 22 (2007) 118-127
25. Hu P., Seeman T.E., Harris T.B., and Reuben D.B. Is serum uric acid level associated with all-cause mortality in high-functioning older persons: MacArthur studies of successful aging?. J Am Geriatr Soc 49 (2001) 1679-1684
26. Dawson J., and Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?. Br J Clin Pharmacol 62 (2006) 633-644
27. Jee S.H., Lee S.Y., and Kim M.T. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 11 (2004) 185-191
28. Strasak A.M., Rapp K., Hilbe W., Oberaigner W., Ruttmann E., Concin H., Diem G., Pfeiffer K.P., and Ulmer H. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 18 (2007) 1021-1029
29. Strasak A., Ruttmann E., Brant L., Kelleher C., Klenk J., Concin H., Diem G., Pfeiffer K., and Ulmer H. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 54 (2008) 273-284
30. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., and Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37 (2006) 1503-1507